Vsee Health Inc (NASDAQ: VSEE) more than doubled after receiving FedRAMP High Authority to Operate (ATO) from the US Department of Health and Human Services (HHS) on Wednesday.
While that opens doors to lucrative federal contracts – a warrant exchange agreement announced this morning simultaneously introduces “immediate” dilution risk as well.
At its intraday peak, Vsee stock was seen trading nearly 200% higher than its low on October 17th.
Why Vsee stock soared on the FedRAMP news
VSEE shares soared on FedRAMP High ATO today as it’s a major credibility boost for the Florida-based company.
It clears the Nasdaq-listed firm to provide secure telehealth services to federal agencies, including disaster response and rural health initiatives.
Milton Chen, the company’s chief executive, called it “a major step in expanding our government partnerships and delivering resilient healthcare infrastructure when and where it’s needed most”.
The certification validates VSEE’s platform for enterprise-grade encryption, HIPAA compliance, and hybrid workflows as well.
In July, the telehealth specialist proved its value during a cyberattack on the only hospital in St. Croix – helping restore emergency services.
With FedRAMP High, Vsee can now scale similar deployments across the federal landscape.
Why VSEE shares must be sold on warrant exchange news
Vsee stock appears ripe for selling following the FedRAMP-triggered retail frenzy, as the company has entered a warrant exchange agreement with Alta Partners LLC.
The investor exercised 130,000 IPO warrants for cash and swapped another 2.25 million warrants for 2.175 million shares of common stock.
While this reduces future warrant overhang, it introduces immediate dilution – adding millions of shares to the float.
The agreement was executed under Section 3(a)(9), meaning new shares are unrestricted and can be sold immediately.
VSEE also agreed to a 10-day standstill on new issuances, reverse splits, and registration filings – which may delay any defence moves.
For traders chasing momentum, this dilution risk is a major red flag.
How to play Vsee Health at current levels
Despite today’s rally, VSEE remains a penny stock trading around $1 only, so it faces a real risk of delisting if price levels fail to sustain.
Being a penny stock also means Vsee is thinly traded, prone to unusual volatility, and vulnerable to pump-and-dump behaviour, which makes it a no-go for seasoned investors.
Additionally, Vsee stock doesn’t currently receive coverage from Wall Street firms either, making price discovery difficult and investor sentiment fragile.
The company, headquartered in Boca Raton, has financials that are speculative at best, with no proven track record of profitability.
Without institutional backing or sustained earnings, VSEE shares’ explosive move looks more like a short-term reaction than a long-term rerating.
In a way, it’s more akin to the meme stock phenomenon instead of a fundamentally driven revaluation based on durable growth or profitability.
The post Vsee stock soars on FedRAMP news but ‘immediate’ dilution risk warrants selling appeared first on Invezz
